LOG IN
SIGN UP
MARKET
ADMP
ADMP
Adamis Pharmaceuticals Corp
NASDAQ
2.170
+0.100
+4.83%
After Hours: 2.100 -0.07 -3.23% 19:05 06/05 EDT
OPEN
2.150
PREV CLOSE
2.070
HIGH
2.171
LOW
2.010
VOLUME
58.61K
TURNOVER
0
52 WEEK HIGH
38.18
52 WEEK LOW
1.910
MARKET CAP
6.05M
P/E (TTM)
-0.2798
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 05/29 17:31
Adamis Pharmaceuticals Corp: Current report
Press release · 05/28 10:46
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 05/26 17:31
ADMP, ONCY and DLO among mid-day movers
Seeking Alpha · 05/26 17:21
Adamis Pharmaceuticals Completes Merger With DMK Pharmaceuticals
Adamis Pharmaceuticals Completes Merger With DMK Pharmaceuticals
MT Newswires · 05/25 17:21
ICPT, MNK and TRMD are among pre market losers
Seeking Alpha · 05/22 12:53
Adamis Pharma slips 19% on plans for reverse stock slip
Seeking Alpha · 05/19 16:34
Adamis Pharmaceuticals Announces 1-For-70 Reverse Stock Split
Benzinga · 05/19 16:08
About ADMP
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company, which is focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products in the allergy, respiratory and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, SYMJEPI (epinephrine) Injection 0.15mg and ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL. SYMJEPI (epinephrine) Injection 0.3mg is approved by the United States Food and Drug Administration (FDA) for use in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more. SYMJEPI (epinephrine) Injection 0.15mg is approved by the FDA for use in the treatment of anaphylaxis for patients weighing 33-65 pounds. ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL is approved by the FDA for the treatment of opioid overdose. The Company's Tempol, is an investigational drug.
Webull offers kinds of Adamis Pharmaceuticals Corp stock information, including NASDAQ:ADMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMP stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading ADMP stock methods without spending real money on the virtual paper trading platform.